<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:52:56Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4017264" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4017264</identifier><datestamp>2014-05-19</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Cell</journal-id>
      <journal-id journal-id-type="iso-abbrev">Mol. Cell</journal-id>
      <journal-title-group>
        <journal-title>Molecular Cell</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1097-2765</issn>
      <issn pub-type="epub">1097-4164</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4017264</article-id>
      <article-id pub-id-type="pmcid">PMC4017264</article-id>
      <article-id pub-id-type="pmc-uid">4017264</article-id>
      <article-id pub-id-type="pmid">24726323</article-id>
      <article-id pub-id-type="publisher-id">S1097-2765(14)00223-8</article-id>
      <article-id pub-id-type="doi">10.1016/j.molcel.2014.03.018</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Molecular Basis and Regulation of OTULIN-LUBAC Interaction</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Elliott</surname>
            <given-names>PaulÂ R.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nielsen</surname>
            <given-names>SofieÂ V.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn2" ref-type="fn">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marco-Casanova</surname>
            <given-names>Paola</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn2" ref-type="fn">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fiil</surname>
            <given-names>BertheÂ Katrine</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Keusekotten</surname>
            <given-names>Kirstin</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mailand</surname>
            <given-names>Niels</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freund</surname>
            <given-names>StefanÂ M.V.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gyrd-Hansen</surname>
            <given-names>Mads</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Komander</surname>
            <given-names>David</given-names>
          </name>
          <email>dk@mrc-lmb.cam.ac.uk</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Medical Research Council Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, UK</aff>
      <aff id="aff2"><label>2</label>Department of Disease Biology, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, 2200 Copenhagen, Denmark</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author <email>dk@mrc-lmb.cam.ac.uk</email></corresp>
        <fn id="fn1">
          <label>3</label>
          <p>Present address: Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK</p>
        </fn>
        <fn id="fn2">
          <label>4</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>08</day>
        <month>5</month>
        <year>2014</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <day>08</day>
        <month>5</month>
        <year>2014</year>
      </pub-date>
      <volume>54</volume>
      <issue>3</issue>
      <fpage>335</fpage>
      <lpage>348</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>9</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>23</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>2</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2014 The Authors</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Summary</title>
        <p>The linear ubiquitin (Ub) chain assembly complex (LUBAC) generates Met1-linked âlinearâ Ub chains that regulate the activation of the nuclear factor ÎºB (NFÎºB) transcription factor and other processes. We recently discovered OTULIN as a deubiquitinase that specifically cleaves Met1-linked polyUb. Now, we show that OTULIN binds via a conserved PUB-interacting motif (PIM) to the PUB domain of the LUBAC component HOIP. Crystal structures and nuclear magnetic resonance experiments reveal the molecular basis for the high-affinity interaction and explain why OTULIN binds the HOIP PUB domain specifically. Analysis of LUBAC-induced NFÎºB signaling suggests that OTULIN needs to be present on LUBAC in order to restrict Met1-polyUb signaling. Moreover, LUBAC-OTULIN complex formation is regulated by OTULIN phosphorylation in the PIM. Phosphorylation of OTULIN prevents HOIP binding, whereas unphosphorylated OTULIN is part of the endogenous LUBAC complex. Our work exemplifies how coordination of ubiquitin assembly and disassembly activities in protein complexes regulates individual Ub linkage types.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Graphical Abstract</title>
        <fig id="undfig1" position="anchor">
          <graphic xlink:href="fx1"/>
        </fig>
      </abstract>
      <abstract abstract-type="author-highlights">
        <title>Highlights</title>
        <p>
          <list list-type="simple">
            <list-item id="u0010">
              <label>â¢</label>
              <p>OTULIN binds the HOIP PUB domain via a conserved N-terminal PUB-interacting motif</p>
            </list-item>
            <list-item id="u0015">
              <label>â¢</label>
              <p>Structural studies reveal specificity determinants for the binary interaction</p>
            </list-item>
            <list-item id="u0020">
              <label>â¢</label>
              <p>Loss of HOIP-OTULIN interaction causes deregulated accumulation of Met1-polyUb</p>
            </list-item>
            <list-item id="u0025">
              <label>â¢</label>
              <p>OTULIN binding to LUBAC is regulated by phosphorylation</p>
            </list-item>
          </list>
        </p>
      </abstract>
      <abstract abstract-type="teaser">
        <p>Elliott etÂ al. show how the linear polyubiquitin-specific deubiquitinase OTULIN binds the linear ubiquitin chain assembly complex (LUBAC). The highly specific nanomolar interaction is mediated by the PUB domain of HOIP and an internal PUB-interacting motif (PIM) in OTULIN. Phosphorylation of the Tyr in the PIM regulates endogenous complex formation.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1">
      <title>Introduction</title>
      <p>Protein ubiquitination is a versatile posttranslational modification in which Lys residues of substrates are modified with the small protein ubiquitin (Ub). Ub can be ubiquitinated itself, giving rise to polyUb chains. PolyUb chains regulate a wide variety of cellular processes ranging from protein degradation to activation of cellular signaling pathways (<xref rid="bib12 bib18" ref-type="bibr">Hershko and Ciechanover, 1998; Komander and Rape, 2012</xref>). Because Ub itself has eight modification sites, a great variety of homotypic and heterotypic chains exist. It is becoming increasingly clear that different polyUb chains encode distinct signals and are independently and specifically assembled, recognized, and disassembled (<xref rid="bib2 bib21" ref-type="bibr">Behrends and Harper, 2011; Kulathu and Komander, 2012</xref>). The most well-studied polyUb signals are Lys48-linked chains that mediate proteasomal degradation (<xref rid="bib12" ref-type="bibr">Hershko and Ciechanover, 1998</xref>) and Lys63-linked chains that have various nondegradative roles in nuclear factor ÎºB (NFÎºB) and other signaling pathways and in the DNA damage response (<xref rid="bib4" ref-type="bibr">Chen and Sun, 2009</xref>).</p>
      <p>Met1-linked or linear chains constitute a further important chain type in NFÎºB signaling (<xref rid="bib33 bib35" ref-type="bibr">Tokunaga and Iwai, 2012; Walczak etÂ al., 2012</xref>). Work by <xref rid="bib17" ref-type="bibr">Kirisako etÂ al. (2006)</xref> identified the linear Ub chain assembly complex (LUBAC), which consists of the chain-assembling E3 ligase HOIP as well as HOIL-1 and SHARPIN (<xref rid="bib35" ref-type="bibr">Walczak etÂ al., 2012</xref>). Importantly, deletion of the LUBAC component SHARPIN in mice (<xref rid="bib9 bib13 bib34" ref-type="bibr">Gerlach etÂ al., 2011; Ikeda etÂ al., 2011; Tokunaga etÂ al., 2011</xref>), or mutation of HOIL-1 in humans (<xref rid="bib3" ref-type="bibr">Boisson etÂ al., 2012</xref>), lead to hyperinflammatory phenotypes, indicating key roles of LUBAC and linear Ub chains in the response to infection and inflammation.</p>
      <p>The remarkable specificity of HOIP for assembling Met1-linked chains resides in its RBR E3 ligase domain and a conserved C-terminal extension (<xref rid="bib27 bib30" ref-type="bibr">Smit etÂ al., 2012; Stieglitz etÂ al., 2012b</xref>) and is now understood in molecular detail (<xref rid="bib31" ref-type="bibr">Stieglitz etÂ al., 2013</xref>). HOIP also comprises several NPL4 zinc finger (NZF) Ub binding domains (UBDs) that target it to ubiquitinated proteins (<xref rid="bib10" ref-type="bibr">Haas etÂ al., 2009</xref>), a Ub-associated (UBA) domain that mediates interactions with HOIL-1 (<xref rid="bib36" ref-type="bibr">Yagi etÂ al., 2012</xref>), and N-terminal PUB (peptide:N-glycanase/UBA- or UBX-containing proteins) and B box domains of unknown functions. PUB domains interact with the C terminus of the AAA+ ATPase p97 (also known as VCP, or cdc48 in yeast), which itself regulates a myriad of cellular signaling pathways, often in conjunction with the Ub system (<xref rid="bib25" ref-type="bibr">Meyer etÂ al., 2012</xref>).</p>
      <p>Until recently, it was unclear how Met1-linked polyUb chains are hydrolyzed, given that many deubiquitinating enzymes (DUBs) are isopeptide specific and unable to hydrolyze Gly76-Met1 peptide bonds in Met1-linked chains (<xref rid="bib19 bib24" ref-type="bibr">Komander etÂ al., 2009; Mevissen etÂ al., 2013</xref>). The majority of USP domain DUBs hydrolyze Met1 linkages with significantly lower activity in comparison to Lys linkages (<xref rid="bib6" ref-type="bibr">Faesen etÂ al., 2011</xref>).</p>
      <p>Two reports recently identified FAM105B/OTULIN as an OTUÂ domain DUB with high activity and unique specificity for Met1-linked polyUb (<xref rid="bib16 bib26" ref-type="bibr">Keusekotten etÂ al., 2013; Rivkin etÂ al., 2013</xref>). OTULIN and LUBAC have coevolved in higher eukaryotes, and OTULIN antagonizes processes involving LUBAC, including tumor necrosis factor Î± (TNFÎ±), poly(I:C), and NOD2 signaling (<xref rid="bib7 bib16" ref-type="bibr">Fiil etÂ al., 2013; Keusekotten etÂ al., 2013</xref>). OTULIN was also implicated in angiogenesis and may affect Wnt signaling (<xref rid="bib26" ref-type="bibr">Rivkin etÂ al., 2013</xref>).</p>
      <p>Knockdown of OTULIN or overexpression of a catalytically inactive mutant results in increased ubiquitination of proteins with Met1 linkages and leads to the ubiquitination of LUBAC itself. This suggests that OTULIN protects LUBAC from autoubiquitination (<xref rid="bib7 bib16" ref-type="bibr">Fiil etÂ al., 2013; Keusekotten etÂ al., 2013</xref>). Moreover, immunoprecipitation of SHARPIN copurified HOIP, HOIL-1 and OTULIN (<xref rid="bib16" ref-type="bibr">Keusekotten etÂ al., 2013</xref>), and OTULIN interacted with HOIP in proteomic experiments (<xref rid="bib8 bib26" ref-type="bibr">Fu etÂ al., 2014; Rivkin etÂ al., 2013</xref>), indicating that OTULIN may associate with HOIP and/or LUBAC.</p>
      <p>Here, we show that OTULIN interacts directly with the N-terminal PUB domain of HOIP via a conserved PUB-interacting motif (PIM) in OTULIN. The OTULIN PIM is necessary and sufficient to establish a high-affinity interaction with HOIP, which isÂ &gt;40-fold higher in affinity than a HOIP-p97 interaction. Structural studies explain this high affinity and the OTULIN-HOIP specificity. Point mutants on either side of the interface disrupt the interaction inÂ vitro and in cells. Loss of the HOIP-OTULIN interaction disables OTULIN-dependent regulation ofÂ HOIP ubiquitination and OTULINâs capacity to efficiently shutdown LUBAC-induced NFÎºB activation, suggesting that OTULIN needs to be present on LUBAC to restrict Met1-polyUb signaling. Furthermore, complex formation is regulated by PIM phosphorylation.</p>
    </sec>
    <sec sec-type="results" id="sec2">
      <title>Results</title>
      <sec id="sec2.1">
        <title>Identification of a HOIP-OTULIN Interaction</title>
        <p>Previous studies of OTULIN had suggested an interaction between OTULIN and LUBAC; however, although <xref rid="bib26" ref-type="bibr">Rivkin etÂ al. (2013)</xref> speculated that OTULIN forms a subcomplex with HOIP alone, we showed that SHARPIN immunoprecipitated OTULIN, HOIL-1, and HOIP (<xref rid="bib16" ref-type="bibr">Keusekotten etÂ al., 2013</xref>). Indeed, immunoprecipitation of overexpressed HOIP, but not HOIL-1, copurified endogenous OTULIN (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>A). HOIP truncations were used to map the region of HOIP that interacts with OTULIN. This indicated that the N-terminal 185 amino acids (aa) spanning the PUB domain of HOIP were sufficient to coimmunoprecipitate endogenous OTULIN (<xref rid="fig1" ref-type="fig">Figures 1</xref>B and 1C). OTULIN interaction was increased in longerÂ constructs (aa 1â436, also including B box and NZF domains); however, this longer construct also interacted with endogenous HOIP, suggesting that it harbors the oligomerization module of HOIP and that oligomerization of HOIP most likely enhances OTULIN binding (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>C). Next, the HOIP-OTULIN interaction was verified inÂ vitro. Constructs spanning the annotated PUB domain (aa 67â158) were insoluble, but including the conserved HOIP N terminus resulted in a stable fragment of HOIP (<xref rid="app3" ref-type="sec">FigureÂ S1</xref>A available online). This extended PUB domain construct (aa 1â184) is able to bind full-length OTULIN in analytical size-exclusion chromatography studies (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>D).</p>
      </sec>
      <sec id="sec2.2">
        <title>Structure of the HOIP PUB Domain</title>
        <p>To understand structural features of the extended HOIP PUB domain, we crystallized and determined its structure to 3.0Â Ã resolution by molecular replacement with the use of coordinates deposited by the Structural Genomics Consortium (SGC; Protein Data Bank [PDB] ID <ext-link ext-link-type="uri" xlink:href="pdb:4JUY" id="intref0010">4JUY</ext-link>
<xref rid="fig1" ref-type="fig">Figures 1</xref>E and <xref rid="app3" ref-type="sec">S1</xref>B and <xref rid="tbl1" ref-type="table">Table 1</xref>). Our structure contains 13 molecules within the asymmetric unit that superimpose with a low root-mean-square deviation (rmsd; 0.9â1.2Â Ã; <xref rid="app3" ref-type="sec">FigureÂ S1</xref>C). As anticipated, residues 59â158 of HOIP form a PUB domain resembling that of PNGase, the only other PUB domain structurally characterized to date (<xref rid="bib1 bib37" ref-type="bibr">Allen etÂ al., 2006; Zhao etÂ al., 2007</xref>). HOIP and PNGase superimpose with an rmsd of 7.2Â Ã for residues 59â158 of HOIP (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>E), and most secondary structure elements are conserved (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>F). In addition, the HOIP PUB domain contains two N-terminal helices and one C-terminal helix that contribute to the hydrophobic core of the PUB domain, revealing why shorter constructs were insoluble (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>F). Hydrophobic residues within the N-terminal extension are conserved among most HOIP orthologs, suggesting that the extended fold is conserved (<xref rid="app3" ref-type="sec">FigureÂ S1</xref>A). A similar extension is not present in the N-terminal PUB domain of PNGase (<xref rid="bib1 bib37" ref-type="bibr">Allen etÂ al., 2006; Zhao etÂ al., 2007</xref>) or in the only other protein in which a PUB domain has been annotated, UBXD1 (<xref rid="bib15" ref-type="bibr">Kern etÂ al., 2009</xref>) (<xref rid="app3" ref-type="sec">FigureÂ S1</xref>D). Consistently, a minimal UBXD1 PUB domain (aa 150â264) is soluble and functional (see below).</p>
      </sec>
      <sec id="sec2.3">
        <title>Functional Surfaces in the HOIP PUB Domain</title>
        <p>The PNGase PUB domain was shown to have two functional surfaces. The first one is the PIM pocket derived from a PNGase crystal structure in complex with a five-residue DDLYG PIM peptide corresponding to the p97 C terminus (<xref rid="bib37" ref-type="bibr">Zhao etÂ al., 2007</xref>). In this interaction, two key residues in the PIM peptide (Leu804 and Tyr805) form mainly hydrophobic interactions with a hydrophobic pocket, the PIM pocket (<xref rid="bib37" ref-type="bibr">Zhao etÂ al., 2007</xref>) (<xref rid="fig1" ref-type="fig">Figures 1</xref>F and <xref rid="fig2" ref-type="fig">2</xref>A, see below). A second functional surface of the PNGase PUB domain is a binding site for Ub or the Ub-like domain of human Rad23 located on the opposite face of the PIM pocket (<xref rid="bib14" ref-type="bibr">Kamiya etÂ al., 2012</xref>).</p>
        <p>To understand whether these functional surfaces were conserved in HOIP, we analyzed surface conservation of its PUB domain (<xref rid="fig2" ref-type="fig">Figures 2</xref>B and <xref rid="app3" ref-type="sec">S1</xref>A). Most surface residues in HOIP, including those potentially involved in Ub interaction, are not conserved. Consistently, we were unable to detect binding of the HOIP PUB domain to Ub or Met1-linked diUb by nuclear magnetic resonance (NMR) analysis (<xref rid="app3" ref-type="sec">FigureÂ S2</xref>).</p>
        <p>In contrast, the residues forming a putative PIM pocket are highly conserved in HOIP. The HOIP PIM pocket is formed by hydrophobic residues located on helices Î±4 (equivalent to helix Î±2 in PNGase, hereafter named Î±A) and Î±5 (equivalent to helix Î±3 in PNGase, hereafter named Î±B) and on the Î²1 strand (compare <xref rid="fig2" ref-type="fig">Figures 2</xref>B and <xref rid="fig1" ref-type="fig">1</xref>E). This suggested that the PIM pocket in HOIP is most likely important for OTULIN binding and that OTULIN might contain a PIM.</p>
      </sec>
      <sec id="sec2.4">
        <title>Identification of a PIM in OTULIN</title>
        <p>Using analytical size-exclusion chromatography analysis, we mapped the HOIP interaction site of OTULIN to its N-terminal 80 aa, which was in agreement with previous data (<xref rid="bib26" ref-type="bibr">Rivkin etÂ al., 2013</xref>) (<xref rid="app3" ref-type="sec">FigureÂ S3</xref>A). Closer inspection of this region revealed low overall conservation, with the exception of a short invariant EEDMYR motif spanning residues 52â57 that resembled the p97 PIM (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>C). We used a fluorescence polarization assay to test whether FITC-labeled OTULIN (aa 49â67) or p97 (aa 797â806) (<xref rid="bib37" ref-type="bibr">Zhao etÂ al., 2007</xref>) peptides were able to bind the HOIP PUB domain. The p97 peptide bound to the HOIP PUB domain with 7.6Â Î¼M affinity, which is similar to other PUB-p97 interactions (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>D, see below). Importantly, the OTULIN peptide bound HOIP with 180Â nM affinity, a &gt;40-fold increase in comparison to p97 (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>D).</p>
        <p>The realization that OTULIN contains a PIM immediately raised the intriguing possibility that OTULIN might interact with other PUB-domain-containing proteins. Hence, the binding of PIM peptides of OTULIN and p97 to the PUB domains of HOIP, PNGase, or UBXD1 was compared. All three domains bound fluorescently labeled p97 PIM peptide with similar affinity (3Â Î¼M for PNGase, 6Â Î¼M for HOIP, and 12Â Î¼M for UBXD1), which was in accordance with published isothermal titration calorimetry data (3Â Î¼M for PNGase; <xref rid="fig2" ref-type="fig">FigureÂ 2</xref>E) (<xref rid="bib37" ref-type="bibr">Zhao etÂ al., 2007</xref>). Interestingly, the OTULIN PIM bound to HOIP, but not to UBXD1 or PNGase, PUB domains (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>F).</p>
      </sec>
      <sec id="sec2.5">
        <title>Characterization of the HOIP-OTULIN Complex by NMR</title>
        <p>We used NMR to further understand the molecular basis of the OTULIN-HOIP interaction. A <sup>15</sup>N-labeled HOIP PUB domain construct (aa 1â184) was analyzed by BEST-TROSY (<xref rid="bib28" ref-type="bibr">Solyom etÂ al., 2013</xref>), revealing well-dispersed peaks (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>G). Triple-resonance experiments with <sup>13</sup>C- and <sup>15</sup>N-labeled HOIP PUB domain protein allowed the assignment of 167 out of 186 amino acids.</p>
        <p>Significant chemical shift perturbations (CSPs) were observed when unlabeled PIM peptides derived from OTULIN or p97 were added to labeled HOIP PUB domain (<xref rid="fig2" ref-type="fig">Figures 2</xref>G and 2H). Both peptides resulted in qualitatively identical CSPs (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>H), suggesting similar binding modes. However, although the p97 peptide displayed CSPs indicative of fast-exchange behavior on the NMR time scale, the OTULIN peptide showed CSPs and loss of a large number of resonances, a feature common to slow exchange (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>G, see also <xref rid="app3" ref-type="sec">FigureÂ S4</xref>A). This is consistent with a &gt;40-fold higher affinity of the OTULIN peptide as observed by fluorescence polarization, and it most likely reflects a higher dynamic equilibrium for the p97 PIM peptide in comparison to a more stable interaction with the OTULIN PIM. A comparison of <sup>13</sup>C-HSQC spectra, which monitor aliphatic side chain resonances, showed that only a small subset of peaks were perturbed. This indicated that peptide binding did not result in large-scale conformational changes in the HOIP PUB domain (<xref rid="app3" ref-type="sec">FigureÂ S3</xref>B).</p>
        <p>Next, we tested whether the extended HOIP PUB domain interacted exclusively via the PIM or whether it formed additional interactions with the OTULIN OTU domain. For this, <sup>15</sup>N-labeled HOIP PUB domain was mixed with full-length OTULIN (aa 1â352), OTULIN ovarian tumor (OTU) domain (aa 80â352), or the OTULIN PIM peptide (aa 49â67, see above). A comparison of the resulting spectra confirmed that the OTU domain did not interact with the HOIP PUB domain (<xref rid="fig2" ref-type="fig">Figures 2</xref>I, see <xref rid="app3" ref-type="sec">Figures S4</xref>B and S4C for the full spectra). Importantly, the pattern of HOIP CSPs was identical upon the addition of either OTULIN PIM peptide or full-length OTULIN (<xref rid="fig2" ref-type="fig">Figures 2</xref>I and 2J). Moreover, despite forming a â¼60Â kDa complex, the spectra of the HOIP PUB domain were unaffected by line broadening, indicating that the PIM in OTULIN is quasi-independent from the OTU domain and displays the dynamic behavior of a small protein (<xref rid="fig2" ref-type="fig">Figures 2</xref>H and <xref rid="app3" ref-type="sec">S4</xref>C). This revealed that the PIM is the sole binding site between OTULIN and the HOIP PUB domain.</p>
      </sec>
      <sec id="sec2.6">
        <title>Structure of the HOIP PUB Domain in Complex with the OTULIN PIM</title>
        <p>Having established the minimal requirements for the HOIP-OTULIN interaction, we set out to crystallize the complex. We determined the structure of a slightly truncated HOIP PUB domain construct (aa 5â180) bound to the OTULIN PIM peptide (aa 49â67) to 2.0Â Ã resolution (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A, <xref rid="tbl1" ref-type="table">Table 1</xref>). The two molecules in the asymmetric unit were highly similar to the apo structures (rmsd â¼1.5Â Ã; <xref rid="app3" ref-type="sec">FigureÂ S5</xref>A), which was consistent with NMR analysis (<xref rid="app3" ref-type="sec">FigureÂ S3</xref>B). Both HOIP molecules showed similarly well-defined electron density for residues 53â65 of the PIM peptide (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>B). In analogy to the p97-PNGase interaction, only PIM residues 54â58 interact with HOIP. The PIM peptide forms a 90Â° kink, in which Met55 and Tyr56 form a bulge and mediate key hydrophobic interactions. Residues 49â52 and 66â67 are disordered in the crystal structure, and residues 53 and 59â65 protrude from the PUB domain without forming contacts.</p>
        <p>As expected, the OTULIN PIM peptide binds to the conserved PIM pocket in the HOIP PUB domain (<xref rid="fig2" ref-type="fig">Figures 2</xref>B andÂ <xref rid="fig3" ref-type="fig">3</xref>). The key PIM residue Tyr56 is buried in a pocket formed by Tyr82 (Î±A), Tyr124, and Pro92 and formed a hydrogen bond with Asn85 from HOIP. The second hydrophobic PIM residue, Met55, is bound in a shallower groove between HOIP PUB domain residues Tyr82, Ile78 (Î±A), and Val104 (Î±B; <xref rid="fig3" ref-type="fig">FigureÂ 3</xref>D). In addition to these hydrophobic contacts, HOIP also forms a total of six hydrogen bonds with the backbone of the PIM peptide (<xref rid="fig3" ref-type="fig">Figures 3</xref>C and 3E).</p>
        <p>Of special interest are Asp54 in the OTULIN PIM peptide and Asn102 in HOIP, given that these residues induce the 90Â° kink in the PIM peptide. Asp54 in the peptide binds in <italic>cis</italic> to the backbone amides of OTULIN Tyr56 and Arg57 and to the Î´-guanidyl group of Arg57. More importantly, Asn102 in the PUB domain acts as the cornerstone around which the peptide is wrapped and interacts with the very same backbone of Asp54, Tyr56, and Arg57. Hence, Asp54 and Asn102 induce the required kinked conformation of the PIM peptide in <italic>cis</italic> and <italic>trans</italic>, respectively, indicating that Asn102 is a key residue in the interaction (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>E).</p>
        <p>Arg57 of the PIM peptide participates in a Ï-Ï stacking network with HOIP Tyr94, which is the only residue that undergoes a significant conformational change within the PIM pocket. In our apo structures, the side chain of Tyr94 is rotated to bind the HOIP Tyr pocket in <italic>cis</italic>, appearing to block access to the PIM pocket (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>F). In the PIM peptide complex, a 90Â° rotation of the Tyr94 side chain displaces it from the PIM pocket (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>G). Interestingly, Tyr94 is displaced from the PIM pocket in the apo structure determined by the SGC (PDB ID <ext-link ext-link-type="uri" xlink:href="pdb:4JUY" id="intref0015">4JUY</ext-link>). However, in this structure, residues from the tobacco etch virus (TEV) protease site constitute a pseudo-PIM and interact in <italic>trans</italic> with the PIM pocket of a neighboring molecule in the crystal lattice (<xref rid="app3" ref-type="sec">FigureÂ S5</xref>B).</p>
        <p>We were able to independently verify the conformational change of Tyr94 upon PIM binding with the use of <sup>13</sup>C-HSQC experiments that allow monitoring changes in aromatic residues. Tyr94 aromatic ring protons undergo significant CSPs upon PIM binding. This suggests conformational opening and closing of the PIM pocket in HOIP (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>H).</p>
      </sec>
      <sec id="sec2.7">
        <title>Probing the HOIP-OTULIN Interaction</title>
        <p>The observed binding modes of the OTULIN PIM peptide with the HOIP PUB domain were validated by mutational analysis. Mutations that affect the size and shape of the hydrophobic PIM pocket (Y82F, V104A, and N85A) reduced binding affinities 10- to 50-fold (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>I). Importantly, even conservative mutation of the aforementioned cornerstone residue Asn102 to Asp (N102D) or Gln (N102Q) abolished HOIP binding to OTULIN (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>I).</p>
        <p>To test mutations in OTULIN, we synthesized fluorescently labeled OTULIN peptides with point mutations in Tyr56 (Y56A, Y56F, and Y56W), Met55 (M55D), and Asp54 (D54A). As anticipated, Y56A and M55D mutations abrogated binding, whereas Y56F or Y56W mutation greatly reduced binding (&gt;400- and 100-fold, respectively). Destabilization of the Asp54-induced conformation of the PIM peptide resulted in a 60-fold reduction of HOIP binding (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>J), indicating that stabilizing the kink in the PIM peptide is crucial for PUB interaction.</p>
      </sec>
      <sec id="sec2.8">
        <title>Understanding OTULIN-HOIP Specificity</title>
        <p>Although the structural data revealed the molecular basis for HOIP-OTULIN interaction, a number of questions regarding the observed specificity of the interaction remained. In particular, HOIP bound p97 with &gt;40-fold reduced affinity in comparison to OTULIN, and the reason for this difference must reside in the distinct PIMs of the two proteins. Second, although p97 was promiscuous, OTULIN was unable to bind other PUB domains, indicating key differences in the involved PUB domains.</p>
        <sec id="sec2.8.1">
          <title>Understanding HOIP Specificity for OTULIN</title>
          <p>To understand these specificity considerations, we compared the binding modes of OTULIN-HOIP to those of p97-PNGase (<xref rid="fig4" ref-type="fig">Figures 4</xref>A and 4B). The key differences in the OTULIN PIM peptide are the C-terminal extension not present in the C-terminal p97 peptide and the exchange of Leu-Tyr-Gly in p97 for Met-Tyr-Arg in OTULIN. Apart from this, the PIM peptides can be superimposed well (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>C).</p>
          <p>A fluorescently labeled OTULIN peptide in which Met55 was exchanged to Leu (as in p97) bound HOIP with near-identical affinity (370Â nM), showing that the small change in the first hydrophobic residue did not account for the difference (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>J). Next, we speculated that HOIP did not form similar interactions with the p97 C terminus. In PNGase, this group forms two hydrogen bonds with the PUB domain residue Arg55 (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>B). In HOIP, the equivalent position is Lys99, the side chain of which does not interact with the OTULIN PIM (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>A). K99R mutation had similar marginal effects on OTULIN or p97 interaction (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>D). HOIP uses Asn101 to bind to Ala59 of the OTULIN PIM (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>A), which has no equivalent in the p97 PIM (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>B), and Asn101 would be too far to contact the p97 C terminus. Importantly, mutation of HOIP Asn101 to ArgÂ improved p97 binding 9-fold (from 7.6â0.9Â Î¼M; <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>D), suggesting that the introduced Arg101 contacts the p97 CÂ terminus and now contributes to the interaction. Interestingly, the N101R mutation does not significantly affect OTULIN interaction (180 versus 100Â nM; <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>D), suggesting that HOIP has selectively weakened p97 interaction in order to gain specificity for OTULIN.</p>
          <p>Despite the high-affinity, and seemingly more stable, interaction between HOIP and OTULIN, the interaction between HOIP and p97 was still significant and similar to other PUB-p97 interactions (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>E). To test whether p97 can still bind HOIP in the presence of OTULIN, we measured its ability to compete for the PIM pocket in a fluorescence polarization competition assay. Interestingly, the p97 PIM peptide competed poorly with the OTULIN PIM for the HOIP binding site (<italic>K</italic><sub><italic>i</italic></sub> of 37Â Î¼M; <xref rid="app3" ref-type="sec">FigureÂ S6</xref>A). This strengthens the observation that the HOIP-OTULIN interaction is significantly more stable than a HOIP-p97 interaction.</p>
        </sec>
        <sec id="sec2.8.2">
          <title>Understanding OTULIN Specificity for HOIP</title>
          <p>Differences in the PIM pocket of HOIP and PNGase explain the observed specificity of OTULIN for the HOIP PUB domain. Superposition of the PIM peptides in both complexes aligns the Î±B helices containing the crucial cornerstone Asn residues and the Î²1 strands. However, the remaining core helices including Î±A display a â¼30Â° rotation, leading to a different overall disposition of hydrophobic residues (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>E). This suggests the presence of a hinge between the helical core (including Î±A) of the PUB domain and the Î±B-Î²1 subdomain. Indeed, the loops between Î±A and Î²1 are well ordered, conserved, and conformationally identical in all structures of the respective PUB domains but structurally highly divergent in HOIP and PNGase (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>E). The HOIP Î±A-Î²1 loop contains Tyr94 that undergoes a conformational change upon PIM binding (see above). In contrast, the equivalent Tyr51 in PNGase provides a seemingly solid sidewall to the PIM pocket and is conformationally rigid. This difference in Tyr positioning and flexibility shapes the PIM pocket, which is deeper in HOIP than it is in PNGase. Consistently, superposition of the PUB domains reveals that the OTULIN PIM has moved by 1.5Â Ã deeper into the HOIP PIM pocket, most likely explaining the observed high affinity for the OTULIN-HOIP interaction (<xref rid="fig4" ref-type="fig">Figures 4</xref>C and <xref rid="app3" ref-type="sec">S6</xref>B).</p>
          <p>Moreover, this difference in size and shape of the PIM pocket explains why PNGase cannot bind OTULIN. Although superposition of the OTULIN PIM onto PNGase does not reveal significant clashes (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>E), the larger Met in the OTULIN PIM (versus Leu in p97) may be too big for PNGase. However, a fluorescently labeled OTULIN PIM with M55L mutation that mimics the Leu-Tyr of the p97 sequence was still unable to bind PNGase (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F). Another key difference in the PUB domains is Arg55 in PNGase, which binds the C terminus and âclosesâ the PIM pocket, potentially disallowing the binding of C-terminally extended PIM peptides, as found in OTULIN. The equivalent Lys101 in HOIP points away from the PIM pocket (see above). Indeed, we started to detect an OTULIN-PNGase interaction when Arg55 was mutated to Ala (<italic>K</italic><sub><italic>D</italic></sub> 43Â Î¼M; <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F). Importantly, when this PNGase mutant was tested with the OTULIN M55L PIM peptide, full binding was recovered (<italic>K</italic><sub><italic>D</italic></sub> 5Â Î¼M; <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F). Hence, with point mutations in OTULIN to generate a more p97-like PIM and in PNGase to remove the requirement for a C-terminal PIM as in p97, we have engineered a Î¼M binding interface in two proteins that did not interact previously. This confirms that the specificity of OTULIN for the HOIP PUB domains originates from a slightly larger PIM pocket in HOIP that allows binding of internal PIMs.</p>
        </sec>
      </sec>
      <sec id="sec2.11">
        <title>Characterization of OTULIN-HOIP Interactions InÂ Vivo</title>
        <p>Having characterized the PUB-PIM interaction inÂ vitro, we wondered whether it was responsible for HOIP-OTULIN interaction in cells. For this, we first overexpressed V5-tagged HOIP wild-type or HOIP with point mutations in the PUB binding site and then tested its ability to coimmunoprecipitate endogenous OTULIN. Although wild-type HOIP coprecipitated OTULIN, mutations Y82A and N102D abrogated OTULIN binding, and Y82F and K99E decreased binding (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>A), which was consistent with the roles of these residues in PIM binding (see above).</p>
        <p>For the reverse experiment, we overexpressed full-length OTULIN or OTULIN with point mutations in the PIM and monitored their interactions with endogenous LUBAC components. HA-tagged OTULIN coimmunoprecipitated all proteins from the endogenous LUBAC complex, whereas mutations of Tyr56 (Y56F, Y56A, and Y56E) abrogated binding. Residual binding was still observed with an OTULIN D54A mutant, which most likely only destabilizes the kink in the PIM peptide (see <xref rid="fig3" ref-type="fig">FigureÂ 3</xref>J). This showed that the HOIP-OTULIN interaction in cells could be modulated by single point mutations on either side of the interface (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>B).</p>
      </sec>
      <sec id="sec2.12">
        <title>Functional Consequences of Modulating the HOIP-OTULIN Interface</title>
        <p>So far, the cellular consequences of OTULIN-LUBAC interaction are unclear. We have previously shown that knockdown of OTULIN or overexpression of a catalytically inactive OTULIN C129A mutant (CA) lead to the autoubiquitination of HOIP with Met1-linked polyUb chains (<xref rid="bib7 bib16" ref-type="bibr">Fiil etÂ al., 2013; Keusekotten etÂ al., 2013</xref>) (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>A, compare lanes 1 and 4; <xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B, compare lanes 1 and 2). We wondered whether this depended on the formation of the OTULIN-HOIP complex or whether OTULIN would act in <italic>trans</italic> on the complex. When coexpressed with HOIL-1, HOIP PUB binding mutants autoubiquitinated in cells expressing endogenous OTULIN, and knockdown of OTULIN did not increase HOIP ubiquitination (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>A). This observation suggests that, under basal conditions, the binding of OTULIN prevents HOIP autoubiquitination. Supporting this, ectopic expression of an inactive OTULIN with a mutation in the PIM (Y56A) did not lead to HOIP autoubiquitination, whereas inactive OTULIN with an intact PIM led to extensive HOIP ubiquitination (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B). Identical results were obtained when the activity of endogenous HOIP was induced by the NOD2 stimulus L18-MDP (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B) or treatment with TNF (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>C). To investigate the functional importance of the HOIP-OTULIN interaction on NFÎºB signaling, we first coexpressed HOIP and HOIL-1 together with wild-type OTULIN or the PIM mutant Y56A. Although OTULIN Y56A was consistently slightly less potent in inhibiting NFÎºB activity in comparison to wild-type OTULIN, the assay revealed the difficulty in comparing different OTULIN variants functionally by overexpression (<xref rid="app3" ref-type="sec">FigureÂ S7</xref>), as reported previously (<xref rid="bib26" ref-type="bibr">Rivkin etÂ al., 2013</xref>).</p>
        <p>Instead, we tested how mutations in the HOIP PUB binding site would affect the capacity of wild-type OTULIN to inhibit LUBAC-induced NFÎºB activity. Importantly, mutation of the cornerstone residue Asn102 to Asp (N102D) or a mutation that affect the hydrophobic PIM pocket (Y82A) reduced the ability of OTULIN to antagonize LUBAC-induced NFÎºB activity in comparison to wild-type HOIP (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>D). This reveals that OTULIN has to be present on LUBAC in order to regulate NFÎºB signaling.</p>
      </sec>
      <sec id="sec2.13">
        <title>Regulation of OTULIN-LUBAC Interaction by Phosphorylation</title>
        <p>Next, we wondered whether OTULIN was indeed part of LUBAC at the endogenous level. For this, we purified the endogenous LUBAC complex from human embryonic kidney 293ET (HEK293ET) cell lysates by gel filtration (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>A). As reported previously (<xref rid="bib17" ref-type="bibr">Kirisako etÂ al., 2006</xref>), HOIP and HOIL-1 formed an approximately 600Â kDa complex, and SHARPIN eluted quantitatively in this size range. The LUBAC complex is of similar size to recombinant p97 hexamers or to cellular p97 complexes. Bacterially purified OTULIN is monomeric and elutes according to its mass at â¼40Â kDa. To our surprise, the majority of endogenous OTULIN in HEK293ET cells (&gt;95%) eluted in a size range of â¼100â150Â kDa, and only a small fraction seemed to coelute with the endogenous LUBAC complex (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>A). Similar data were obtained in U2OS and RPE1 cells (<xref rid="app3" ref-type="sec">FigureÂ S8</xref>). This was in contrast to our findings that the HOIP PUB-OTULIN interaction was stable on gel filtration (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>D). Although there were many potential reasons for why the interaction was unstable in cells, one intriguing possibility was that binding of OTULIN toÂ HOIP was dynamically regulated. Indeed, OTULIN is phosphorylated in cells, and the prime site for phosphorylation is the PIM residue Tyr56 (<ext-link ext-link-type="uri" xlink:href="http://phosphosite.org/proteinAction.do?id=2470471" id="intref0020">http://phosphosite.org/proteinAction.do?id=2470471</ext-link>; <xref rid="fig7" ref-type="fig">FigureÂ 7</xref>B). A Tyr56-phosphorylated PIM peptide was unable to bind HOIP, which is consistent with our structural data (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>C). Importantly, the distribution of OTULIN changed significantly when HEK293ET lysates were prepared in the absence of phosphatase inhibitors. Although OTULIN eluted in a single peak when phosphatases are inhibited (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>A), phosphatase activity resulted in two peaks at 600 and 40Â kDa. This suggested that OTULIN is indeed phosphorylated in HEK293ET cell lysates and that dephosphorylation leads to quantitative association with LUBAC. OTULIN may be more abundant than LUBAC and HOIP, given that a significant fraction of dephosphorylated OTULIN is not bound to HOIP and elutes as a monomer. Altogether, this suggests that the abundance of OTULIN on LUBAC is regulated by phosphorylation of the OTULIN PIM.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="sec3">
      <title>Discussion</title>
      <p>Here, we reveal the molecular basis for the interaction of Met1-processing machineries, namely between the chain assembling LUBAC complex and the Met1-specific DUB, OTULIN. This is yet another example of interaction of a DUB with an E3 ligase in analogy to well-established complexes such as MDM2-USP7 (<xref rid="bib22" ref-type="bibr">Li etÂ al., 2004</xref>) or BRAP-USP15 (<xref rid="bib11" ref-type="bibr">Hayes etÂ al., 2012</xref>). What is unique about this complex is that all components are exquisitely specific for Met1-linked polyUb. The entire machinery appears to have coevolved to regulate this particular Ub chain type, and it is tempting to speculate that other chain types are regulated in a similar manner. We recently showed that OTU domain DUBs are highly linkage specific and include members with defined preference for rare atypical linkages (<xref rid="bib24" ref-type="bibr">Mevissen etÂ al., 2013</xref>). It will be interesting to see whether these DUBs associate with E3 ligases to form chain-type-specific processing complexes.</p>
      <p>Our work assigns a function to the previously unstudied PUB domain of HOIP, which mediates the interaction with a short, conserved PIM in the OTULIN N terminus. PUB domains are found in only a handful of proteins that bind p97, including PNGase and UBXD1 (<xref rid="bib1 bib32" ref-type="bibr">Allen etÂ al., 2006; Suzuki etÂ al., 2001</xref>). UBXD1 also contains a UBX domain and binds p97 via two interfaces (<xref rid="bib15" ref-type="bibr">Kern etÂ al., 2009</xref>). Interestingly, despite structural similarity and HOIP's ability to bind p97 peptides with similar affinity to other PUB domains, PNGase or UBXD1 cannot bind OTULIN. Moreover, PUB domains were not known to bind to internal sequences, and we show that a two-residue hydrophobic motif and a kink in the PIM peptide is necessary for interacting with PUB domains. This realization may lead to the identification of PIMs in other proteins and binding partners for PUB domain proteins, including HOIP. Although the shortness of the motif poses significant challenges to identifying PIMs by bioinformatic means, recent methods to predict that similarly short LC3-interacting motifs may be applicable (<xref rid="bib20" ref-type="bibr">Kraft etÂ al., 2012</xref>).</p>
      <p>Despite its importance, the composition of the LUBAC complex is currently unclear. HOIP (120Â kDa) and HOIL-1 (58Â kDa) form a â¼600Â kDa complex when purified from eukaryotic cells (<xref rid="bib17" ref-type="bibr">Kirisako etÂ al., 2006</xref>). Subsequently, SHARPIN (40Â kDa) was shown to be an additional LUBAC component (<xref rid="bib9 bib13 bib34" ref-type="bibr">Gerlach etÂ al., 2011; Ikeda etÂ al., 2011; Tokunaga etÂ al., 2011</xref>) and was subsequently shown to dimerize (<xref rid="bib29" ref-type="bibr">Stieglitz etÂ al., 2012a</xref>). Here, we reveal that also SHARPIN participates in a 600Â kDa LUBAC complex. Although all three proteins readily coimmunoprecipitate, suggesting a trimeric complex (see <xref rid="bib5" ref-type="bibr">Emmerich etÂ al., 2013</xref>), the gel filtration analysis does not exclude the presence of HOIP/HOIL-1 or HOIP/SHARPIN subcomplexes. Neither SHARPIN nor HOIL-1 can bind the PUB domain of HOIP (they contain one Tyr each and have no PIM), which would be free to interact with OTULIN or p97. We show that HOIP greatly favors OTULIN, and that p97 concentration must be rather high in order to compete with OTULIN if bound. However, given that p97 is a hexamer and HOIP is oligomeric, an interaction of complexes would most likely have improved binding properties.</p>
      <p>Our study provides evidence that OTULIN regulates LUBAC-assembled Met1-polyUb through direct interaction with the HOIP PUB domain and that this might regulate LUBACâs signaling capacity. Moreover, we show that endogenous OTULIN can be part of the endogenous LUBAC complex; however, this is prevented by the phosphorylation of the OTULIN PIM Tyr residue. The involved protein kinase(s) and phosphatase(s) and the dynamics of this phosphorylation event need additional investigation. The regulation of PUB-PIM interactions by phosphorylation was previously shown also for p97, in which PIM phosphorylation blocks PNGase interaction and affects endoplasmic-reticulum-associated protein degradation (<xref rid="bib23" ref-type="bibr">Li etÂ al., 2008</xref>). To fully understand the physiological consequences of the OTULIN-HOIP interaction, genetic models such as knockin animals or cell lines are required, and the dynamics of OTULIN phosphorylation need to be understood. Nonetheless, our characterization of OTULIN as a direct binding partner for LUBAC, and the realization that this interaction is regulated by phosphorylation, improves our understanding of the important Met1-polyUb-regulating machinery in cells and provides an elegant model as to how individual Ub chain types may be regulated by specific DUB-E3 pairs.</p>
    </sec>
    <sec sec-type="methods" id="sec4">
      <title>Experimental Procedures</title>
      <p>Additional details on all methods can be found in the <xref rid="app3" ref-type="sec">Supplemental Experimental Procedures</xref>.</p>
      <sec id="sec4.1">
        <title>Protein Expression and Purification</title>
        <p>Proteins were expressed from pOPINB vectors in Rosetta2 (DE3) pLacI cells.Â For NMR studies, cells were grown in 2M9 medium supplemented withÂ <sup>15</sup>N NH<sub>4</sub>Cl and/or <sup>13</sup>C glucose. Proteins were purified by immobilized metal-affinity, anion-exchange, and size-exclusion chromatography.</p>
      </sec>
      <sec id="sec4.2">
        <title>Crystal Structure Analysis</title>
        <p>Crystallization conditions were screened by the vapor diffusion method. Apo HOIP was determined by molecular replacement with SGC coordinates (PDB ID <ext-link ext-link-type="uri" xlink:href="pdb:4JUY" id="intref0025">4JUY</ext-link>) as a search model. The HOIP-OTULIN PIM structure was determined by molecular replacement with the apo HOIP structure.</p>
      </sec>
      <sec id="sec4.3">
        <title>NMR Spectroscopy</title>
        <p>Standard triple-resonance experiments (HNCA, HN(CO)CA, HNCACB, CBCA(CO)NH, and HBHA(CO)NH) were acquired for the assignment of HOIP resonances. Constant time <sup>13</sup>C and <sup>13</sup>C-HSQC were acquired for the methyl and aromatic regions. In addition, (HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE experiments coupled the CÎ² of tyrosine resonances to the HÎ´ and HÎµ positions of the tyrosine ring, respectively.</p>
      </sec>
      <sec id="sec4.4">
        <title>Fluorescence Polarization Binding Assays</title>
        <p>Serially diluted PUB domains and HOIP variants were mixed with an equal volume of 100Â nM FITC-Ahx-labeled peptides of OTULIN and p97. Fluorescence polarization was recorded on a PheraStar plate reader (BMG LABTECH) and fitted to a one-site binding model with GraphPad Prism 5.</p>
      </sec>
      <sec id="sec4.5">
        <title>Immunoprecipitation of HOIP-V5 and HA-OTULIN</title>
        <p>Transfected HEK293T or U2OS and NOD2 cells were lysed in the presence of protease and phosphatase inhibitors. Clarified lysates were incubated overnight with anti-V5 and anti-HA-agarose resin.</p>
      </sec>
      <sec id="sec4.6">
        <title>Luciferase Reporter Assays</title>
        <p>Cells were cotransfected with the NFÎºB luciferase reporter construct pBIIXluc and the thymidine kinase-renilla luciferase construct in addition to other vectors used in the study. After 24Â hr, cells were lysed in passive lysis buffer (Promega), and luciferase activity was recorded. Protein expression levels were determined by western blotting of cell lysates.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>Allen</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Buchberger</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bycroft</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>The PUB domain functions as a p97 binding module in human peptide N-glycanase</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>25502</fpage>
          <lpage>25508</lpage>
          <pub-id pub-id-type="pmid">16807242</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal" id="sref2">
          <person-group person-group-type="author">
            <name>
              <surname>Behrends</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>Constructing and decoding unconventional ubiquitin chains</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>18</volume>
          <year>2011</year>
          <fpage>520</fpage>
          <lpage>528</lpage>
          <pub-id pub-id-type="pmid">21540891</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>Boisson</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Laplantine</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Prando</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Giliani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Israelsson</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Abhyankar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>IsraÃ«l</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Trevejo-Nunez</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bogunovic</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency</article-title>
          <source>Nat. Immunol.</source>
          <volume>13</volume>
          <year>2012</year>
          <fpage>1178</fpage>
          <lpage>1186</lpage>
          <pub-id pub-id-type="pmid">23104095</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal" id="sref4">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Z.J.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>L.J.</given-names>
            </name>
          </person-group>
          <article-title>Nonproteolytic functions of ubiquitin in cell signaling</article-title>
          <source>Mol. Cell</source>
          <volume>33</volume>
          <year>2009</year>
          <fpage>275</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">19217402</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal" id="sref5">
          <person-group person-group-type="author">
            <name>
              <surname>Emmerich</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Ordureau</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Strickson</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Arthur</surname>
              <given-names>J.S.C.</given-names>
            </name>
            <name>
              <surname>Pedrioli</surname>
              <given-names>P.G.A.</given-names>
            </name>
            <name>
              <surname>Komander</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>110</volume>
          <year>2013</year>
          <fpage>15247</fpage>
          <lpage>15252</lpage>
          <pub-id pub-id-type="pmid">23986494</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal" id="sref6">
          <person-group person-group-type="author">
            <name>
              <surname>Faesen</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Luna-Vargas</surname>
              <given-names>M.P.A.</given-names>
            </name>
            <name>
              <surname>Geurink</surname>
              <given-names>P.P.</given-names>
            </name>
            <name>
              <surname>Clerici</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Merkx</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>van Dijk</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Hameed</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>El Oualid</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ovaa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sixma</surname>
              <given-names>T.K.</given-names>
            </name>
          </person-group>
          <article-title>The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types</article-title>
          <source>Chem. Biol.</source>
          <volume>18</volume>
          <year>2011</year>
          <fpage>1550</fpage>
          <lpage>1561</lpage>
          <pub-id pub-id-type="pmid">22195557</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal" id="sref7">
          <person-group person-group-type="author">
            <name>
              <surname>Fiil</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Damgaard</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Keusekotten</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fritsch</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bekker-Jensen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mailand</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Choudhary</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Komander</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gyrd-Hansen</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>OTULIN restricts Met1-linked ubiquitination to control innate immune signaling</article-title>
          <source>Mol. Cell</source>
          <volume>50</volume>
          <year>2013</year>
          <fpage>818</fpage>
          <lpage>830</lpage>
          <pub-id pub-id-type="pmid">23806334</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Fu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Berman</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Dorf</surname>
              <given-names>M.E.</given-names>
            </name>
          </person-group>
          <article-title>The ubiquitin conjugating enzyme UBE2L3 regulates TNFÎ±-induced linear ubiquitination</article-title>
          <source>Cell Res.</source>
          <volume>24</volume>
          <year>2014</year>
          <fpage>376</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">24060851</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal" id="sref9">
          <person-group person-group-type="author">
            <name>
              <surname>Gerlach</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Cordier</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Schmukle</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Emmerich</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Rieser</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Rickard</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Anderton</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>W.W.-L.</given-names>
            </name>
          </person-group>
          <article-title>Linear ubiquitination prevents inflammation and regulates immune signalling</article-title>
          <source>Nature</source>
          <volume>471</volume>
          <year>2011</year>
          <fpage>591</fpage>
          <lpage>596</lpage>
          <pub-id pub-id-type="pmid">21455173</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal" id="sref10">
          <person-group person-group-type="author">
            <name>
              <surname>Haas</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Emmerich</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Gerlach</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Schmukle</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Cordier</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Rieser</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Feltham</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Vince</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Warnken</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Wenger</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction</article-title>
          <source>Mol. Cell</source>
          <volume>36</volume>
          <year>2009</year>
          <fpage>831</fpage>
          <lpage>844</lpage>
          <pub-id pub-id-type="pmid">20005846</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <name>
              <surname>Hayes</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sanderson</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Coulson</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Clague</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>UrbÃ©</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>287</volume>
          <year>2012</year>
          <fpage>43007</fpage>
          <lpage>43018</lpage>
          <pub-id pub-id-type="pmid">23105109</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal" id="sref12">
          <person-group person-group-type="author">
            <name>
              <surname>Hershko</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ciechanover</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The ubiquitin system</article-title>
          <source>Annu. Rev. Biochem.</source>
          <volume>67</volume>
          <year>1998</year>
          <fpage>425</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="pmid">9759494</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Ikeda</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Deribe</surname>
              <given-names>Y.L.</given-names>
            </name>
            <name>
              <surname>SkÃ¥nland</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Stieglitz</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Grabbe</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Franz-Wachtel</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>van Wijk</surname>
              <given-names>S.J.L.</given-names>
            </name>
            <name>
              <surname>Goswami</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nagy</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Terzic</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>SHARPIN forms a linear ubiquitin ligase complex regulating NF-ÎºB activity and apoptosis</article-title>
          <source>Nature</source>
          <volume>471</volume>
          <year>2011</year>
          <fpage>637</fpage>
          <lpage>641</lpage>
          <pub-id pub-id-type="pmid">21455181</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal" id="sref14">
          <person-group person-group-type="author">
            <name>
              <surname>Kamiya</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Uekusa</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sumiyoshi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sasakawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hirao</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>NMR characterization of the interaction between the PUB domain of peptide:N-glycanase and ubiquitin-like domain of HR23</article-title>
          <source>FEBS Lett.</source>
          <volume>586</volume>
          <year>2012</year>
          <fpage>1141</fpage>
          <lpage>1146</lpage>
          <pub-id pub-id-type="pmid">22575648</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Kern</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fernandez-SÃ¡iz</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>SchÃ¤fer</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Buchberger</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>UBXD1 binds p97 through two independent binding sites</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>380</volume>
          <year>2009</year>
          <fpage>303</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="pmid">19174149</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal" id="sref16">
          <person-group person-group-type="author">
            <name>
              <surname>Keusekotten</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Glockner</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Fiil</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Damgaard</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Kulathu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wauer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hospenthal</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Gyrd-Hansen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Krappmann</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin</article-title>
          <source>Cell</source>
          <volume>153</volume>
          <year>2013</year>
          <fpage>1312</fpage>
          <lpage>1326</lpage>
          <pub-id pub-id-type="pmid">23746843</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>Kirisako</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kamei</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Murata</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fukumoto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kanie</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sano</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tokunaga</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Iwai</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>A ubiquitin ligase complex assembles linear polyubiquitin chains</article-title>
          <source>EMBO J.</source>
          <volume>25</volume>
          <year>2006</year>
          <fpage>4877</fpage>
          <lpage>4887</lpage>
          <pub-id pub-id-type="pmid">17006537</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal" id="sref18">
          <person-group person-group-type="author">
            <name>
              <surname>Komander</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Rape</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>The ubiquitin code</article-title>
          <source>Annu. Rev. Biochem.</source>
          <volume>81</volume>
          <year>2012</year>
          <fpage>203</fpage>
          <lpage>229</lpage>
          <pub-id pub-id-type="pmid">22524316</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Komander</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Reyes-Turcu</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Licchesi</surname>
              <given-names>J.D.F.</given-names>
            </name>
            <name>
              <surname>Odenwaelder</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wilkinson</surname>
              <given-names>K.D.</given-names>
            </name>
            <name>
              <surname>Barford</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains</article-title>
          <source>EMBO Rep.</source>
          <volume>10</volume>
          <year>2009</year>
          <fpage>466</fpage>
          <lpage>473</lpage>
          <pub-id pub-id-type="pmid">19373254</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal" id="sref20">
          <person-group person-group-type="author">
            <name>
              <surname>Kraft</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kijanska</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kalie</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Siergiejuk</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Semplicio</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Stoffel</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Brezovich</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Verma</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hansmann</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Binding of the Atg1/ULK1 kinase to the ubiquitin-like protein Atg8 regulates autophagy</article-title>
          <source>EMBO J.</source>
          <volume>31</volume>
          <year>2012</year>
          <fpage>3691</fpage>
          <lpage>3703</lpage>
          <pub-id pub-id-type="pmid">22885598</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal" id="sref21">
          <person-group person-group-type="author">
            <name>
              <surname>Kulathu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Komander</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>13</volume>
          <year>2012</year>
          <fpage>508</fpage>
          <lpage>523</lpage>
          <pub-id pub-id-type="pmid">22820888</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal" id="sref22">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Kon</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>A dynamic role of HAUSP in the p53-Mdm2 pathway</article-title>
          <source>Mol. Cell</source>
          <volume>13</volume>
          <year>2004</year>
          <fpage>879</fpage>
          <lpage>886</lpage>
          <pub-id pub-id-type="pmid">15053880</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal" id="sref23">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schindelin</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Lennarz</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title>Tyrosine phosphorylation of ATPase p97 regulates its activity during ERAD</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>375</volume>
          <year>2008</year>
          <fpage>247</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="pmid">18706391</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal" id="sref24">
          <person-group person-group-type="author">
            <name>
              <surname>Mevissen</surname>
              <given-names>T.E.T.</given-names>
            </name>
            <name>
              <surname>Hospenthal</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Geurink</surname>
              <given-names>P.P.</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Akutsu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Arnaudo</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ekkebus</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kulathu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wauer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>El Oualid</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis</article-title>
          <source>Cell</source>
          <volume>154</volume>
          <year>2013</year>
          <fpage>169</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">23827681</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal" id="sref25">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bug</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bremer</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system</article-title>
          <source>Nat. Cell Biol.</source>
          <volume>14</volume>
          <year>2012</year>
          <fpage>117</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="pmid">22298039</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal" id="sref26">
          <person-group person-group-type="author">
            <name>
              <surname>Rivkin</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Ceccarelli</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Juang</surname>
              <given-names>Y.-C.</given-names>
            </name>
            <name>
              <surname>MacLean</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Srikumar</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Dunham</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Fukumura</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis</article-title>
          <source>Nature</source>
          <volume>498</volume>
          <year>2013</year>
          <fpage>318</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">23708998</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal" id="sref27">
          <person-group person-group-type="author">
            <name>
              <surname>Smit</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Monteferrario</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Noordermeer</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>van Dijk</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>van der Reijden</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Sixma</surname>
              <given-names>T.K.</given-names>
            </name>
          </person-group>
          <article-title>The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension</article-title>
          <source>EMBO J.</source>
          <volume>31</volume>
          <year>2012</year>
          <fpage>3833</fpage>
          <lpage>3844</lpage>
          <pub-id pub-id-type="pmid">22863777</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal" id="sref28">
          <person-group person-group-type="author">
            <name>
              <surname>Solyom</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Schwarten</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Geist</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Konrat</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Willbold</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Brutscher</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>BEST-TROSY experiments for time-efficient sequential resonance assignment of large disordered proteins</article-title>
          <source>J.Â Biomol. NMR</source>
          <volume>55</volume>
          <year>2013</year>
          <fpage>311</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="pmid">23435576</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal" id="sref29">
          <person-group person-group-type="author">
            <name>
              <surname>Stieglitz</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Haire</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Dikic</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Rittinger</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Structural analysis of SHARPIN, a subunit of a large multi-protein E3 ubiquitin ligase, reveals a novel dimerization function for the pleckstrin homology superfold</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>287</volume>
          <year>2012</year>
          <fpage>20823</fpage>
          <lpage>20829</lpage>
          <pub-id pub-id-type="pmid">22549881</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal" id="sref30">
          <person-group person-group-type="author">
            <name>
              <surname>Stieglitz</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Morris-Davies</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Koliopoulos</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Christodoulou</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rittinger</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>LUBAC synthesizes linear ubiquitin chains via a thioester intermediate</article-title>
          <source>EMBO Rep.</source>
          <volume>13</volume>
          <year>2012</year>
          <fpage>840</fpage>
          <lpage>846</lpage>
          <pub-id pub-id-type="pmid">22791023</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal" id="sref31">
          <person-group person-group-type="author">
            <name>
              <surname>Stieglitz</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Rana</surname>
              <given-names>R.R.</given-names>
            </name>
            <name>
              <surname>Koliopoulos</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Morris-Davies</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Schaeffer</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Christodoulou</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Howell</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>N.R.</given-names>
            </name>
            <name>
              <surname>Dikic</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Rittinger</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP</article-title>
          <source>Nature</source>
          <volume>503</volume>
          <year>2013</year>
          <fpage>422</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="pmid">24141947</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal" id="sref32">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Till</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Lennarz</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title>The PUB domain: a putative protein-protein interaction domain implicated in the ubiquitin-proteasome pathway</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>287</volume>
          <year>2001</year>
          <fpage>1083</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="pmid">11587532</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal" id="sref33">
          <person-group person-group-type="author">
            <name>
              <surname>Tokunaga</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Iwai</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses</article-title>
          <source>Microbes Infect.</source>
          <volume>14</volume>
          <year>2012</year>
          <fpage>563</fpage>
          <lpage>572</lpage>
          <pub-id pub-id-type="pmid">22309894</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal" id="sref34">
          <person-group person-group-type="author">
            <name>
              <surname>Tokunaga</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakahara</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Saeki</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sakata</surname>
              <given-names>S.-I.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Iwai</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>SHARPIN is a component of the NF-ÎºB-activating linear ubiquitin chain assembly complex</article-title>
          <source>Nature</source>
          <volume>471</volume>
          <year>2011</year>
          <fpage>633</fpage>
          <lpage>636</lpage>
          <pub-id pub-id-type="pmid">21455180</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal" id="sref35">
          <person-group person-group-type="author">
            <name>
              <surname>Walczak</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Iwai</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dikic</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Generation and physiological roles of linear ubiquitin chains</article-title>
          <source>BMC Biol.</source>
          <volume>10</volume>
          <year>2012</year>
          <fpage>23</fpage>
          <pub-id pub-id-type="pmid">22420778</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal" id="sref36">
          <person-group person-group-type="author">
            <name>
              <surname>Yagi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ishimoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hiromoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mizushima</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Uekusa</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yagi-Utsumi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kurimoto</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Noda</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Uchiyama</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>A non-canonical UBA-UBL interaction forms the linear-ubiquitin-chain assembly complex</article-title>
          <source>EMBO Rep.</source>
          <volume>13</volume>
          <year>2012</year>
          <fpage>462</fpage>
          <lpage>468</lpage>
          <pub-id pub-id-type="pmid">22430200</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal" id="sref37">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schindelin</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Lennarz</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title>Studies on peptide:N-glycanase-p97 interaction suggest that p97 phosphorylation modulates endoplasmic reticulum-associated degradation</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>104</volume>
          <year>2007</year>
          <fpage>8785</fpage>
          <lpage>8790</lpage>
          <pub-id pub-id-type="pmid">17496150</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app1">
      <title>Accession Numbers</title>
      <p>Coordinates and structure factors have been deposited to the PDB under accession numbers <ext-link ext-link-type="uri" xlink:href="pdb:4OYJ" id="intref0030">4OYJ</ext-link> (HOIP-PUB domain) and <ext-link ext-link-type="uri" xlink:href="pdb:4OYK" id="intref0035">4OYK</ext-link> (HOIP-PUB in complex with OTULIN PIM).</p>
    </sec>
    <sec id="app3" sec-type="supplementary-material">
      <title>Supplemental Information</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Supplemental Experimental Procedures and Figures S1âS8</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Document S2. Article plus Supplemental Information</title>
          </caption>
          <media xlink:href="mmc2.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p>We would like to thank Mark Allen, Mark Bycroft, Trevor Rutherford, Garib Murshudov, Stephen McLaughlin, Chris Johnson, Andrew McKenzie (MRC LMB), Rasmus Hartmann-Petersen (University of Copenhagen), and members of the D.K. and M.G.-H. labs for advice, reagents, and critical comments on the manuscript. We would like to thank beamline staff at Diamond Light Source beamlines I02 and I04. This work was supported by the Medical Research Council (U105192732), the European Research Council (309756), the Lister Institute for Preventive Medicine, the EMBO Young Investigator Program (all D.K.), the Novo Nordisk Foundation (M.G.-H., S.V.N., B.K.F., and N.M.), the Lundbeck Foundation (S.V.N. and M.G.-H.), and a Steno Fellowship from the Danish Council for Independent Research (M.G.-H.). D.K. is a part of the DUB Alliance, which includes Cancer Research Technology and FORMA Therapeutics.</p>
    </ack>
    <fn-group>
      <fn id="d32e461">
        <p>This is an open access article under the CC BY license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/" id="ccintref0005">http://creativecommons.org/licenses/by/3.0/</ext-link>).</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>FigureÂ 1</label>
      <caption>
        <p>OTULIN Binds the HOIP PUB Domain</p>
        <p>(A) Epitope-tagged HOIP or HOIL-1 were transfected into HEK293T cells, and interaction with endogenous OTULIN was determined by immunoprecipitation followed by western blot analysis. OTULIN interacts with HOIP but not HOIL-1 under these conditions.</p>
        <p>(B) Domain representation of HOIP. A bar graph below indicates constructs used for domain mapping.</p>
        <p>(C) Domains of epitope-tagged HOIP were transfected into U2OS and NOD2 cells and probed for endogenous OTULIN following the coimmunoprecipitation described in (A).</p>
        <p>(D) Analytical size-exclusion chromatography profile of HOIP 1-184 (blue), full-length OTULIN (red), and 1:1.2 OTULIN:HOIP complex (black). Coomassie-stained SDS-PAGE gels below show protein-containing fractions.</p>
        <p>(E) Left, extended HOIP PUB domain structure (blue). Middle left, HOIP PUB domain structure determined by the SGC (green, PDB ID <ext-link ext-link-type="uri" xlink:href="pdb:4JUY" id="intref0045">4JUY</ext-link>). Middle right, structure of PNGase PUB domain (orange, PDB ID <ext-link ext-link-type="uri" xlink:href="pdb:2HPL" id="intref0050">2HPL</ext-link>) (<xref rid="bib37" ref-type="bibr">Zhao etÂ al., 2007</xref>). Right, superposition. The SGC-determined HOIP structure includes an additional TEV protease cleavage site at the N terminus (see also <xref rid="app3" ref-type="sec">FigureÂ S5</xref>B).</p>
        <p>(F) Structure-based sequence alignment of HOIP and PNGase PUB domains. HOIP contains two additional N-terminal helices and an additional C-terminal helix not found in PNGase. Open circles represent residues in HOIP (blue), and PNGase (yellow) that interact with the OTULIN/p97 PIMs, respectively.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>FigureÂ 2</label>
      <caption>
        <p>A PUB-Domain-Interacting Motif in OTULIN</p>
        <p>(A) Structure of PNGase bound to the p97 PIM peptide (PDB ID <ext-link ext-link-type="uri" xlink:href="pdb:2HPL" id="intref0055">2HPL</ext-link>) (<xref rid="bib37" ref-type="bibr">Zhao etÂ al., 2007</xref>) reveals the position of the PIM pocket.</p>
        <p>(B) Surface conservation analysis of the HOIP PUB domain colored according to the sequence alignment in <xref rid="app3" ref-type="sec">FigureÂ S1</xref>A. The PIM pocket is highly conserved, whereas other regions, including the surface generated by the N-terminal PUB domain extension, are not conserved.</p>
        <p>(C) Primary sequence alignment of the HOIP binding region in OTULIN (<xref rid="app3" ref-type="sec">FigureÂ S3</xref>A) (<xref rid="bib26" ref-type="bibr">Rivkin etÂ al., 2013</xref>). Alignment shows that the patch with highest evolutionary conservation resembles the p97 PIM.</p>
        <p>(D) Affinity measurements using HOIP PUB domain against FITC-Ahx-labeled p97 PIM peptide (aa 797â806) and OTULIN PIM peptide (aa 49â67). Experiments were performed in triplicate, and errors represent SD from the mean.</p>
        <p>(E) Binding of PUB domains from HOIP (aa 1â184, red), PNGase (aa 11â109, green), and UBXD1 (aa 150â264, magenta) to a fluorescent p97 PIM peptide (aa 797â806) as in (D). <italic>K</italic><sub><italic>D</italic></sub> values are indicated, and errors represent SD from the mean from triplicate experiments.</p>
        <p>(F) Binding of PUB domains as in (E) to the OTULIN PIM peptide.</p>
        <p>(G) <sup>15</sup>N-transverse relaxation optimized spectroscopy (TROSY) spectra of HOIP alone (black), HOIP bound to OTULIN PIM peptide at a 1:1 molar ratio (red), and HOIP bound to p97 PIM peptide at a 1:1 (blue) and 1:4 ratio (green). Selected perturbed resonances are shown. For the full spectra, see <xref rid="app3" ref-type="sec">FigureÂ S4</xref>A.</p>
        <p>(H) Chemical shift map by HOIP residue number for perturbation by p97 and OTULIN PIM peptides.</p>
        <p>(I) <sup>15</sup>N-TROSY spectra of HOIP alone (black), HOIP bound to OTULIN PIM peptide (red), HOIP bound to full-length OTULIN (blue), and HOIP with OTULIN catalytic domain (aa 80â352, yellow), all at a 1:1 molar ratio. The same resonances as in (G) are shown. For the full spectra, see <xref rid="app3" ref-type="sec">Figures S4</xref>B, <xref rid="fig4" ref-type="fig">4</xref>C, and <xref rid="fig3" ref-type="fig">3</xref>.</p>
        <p>(J) Difference map of chemical shifts between HOIP bound to PIM peptide or full-length OTULIN derived from respective spectra in (I).</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>FigureÂ 3</label>
      <caption>
        <p>Structure of HOIP Bound to OTULIN Peptide</p>
        <p>(A) Structure of HOIP PUB domain (aa 5â180; blue) bound to the OTULIN PIM peptide (yellow). The peptide is in ball-and-stick representation with blue nitrogen and red oxygen atoms.</p>
        <p>(B) A weighted 2|Fo|-|Fc| map contoured at 1 Ï covering the OTULIN PIM peptide colored as in (A).</p>
        <p>(C) LIGPLOT representation of the HOIP-OTULIN interaction. Residues in the PIM (aa 53â57) are shown in yellow, and the C-terminal extension of the PIM is shown in orange. Hydrogen bonds are shown by green dashes, and van der Waals contacts are shown as red fans.</p>
        <p>(D) PIM pocket shown in surface representation in the HOIP-OTULIN complex colored as in (A). Residues 92â94, including the mobile Tyr94, are colored green.</p>
        <p>(E) Close-up view of the OTULIN PIM peptide in the HOIP PIM pocket, colored as in (A), showing hydrogen bonds as orange dotted lines.</p>
        <p>(F) PIM pocket shown in surface representation in apo HOIP, in which Tyr94 (green) partly occludes the PIM pocket.</p>
        <p>(G) Superposition of apo and PIM-peptide-bound HOIP highlighting the conformational change in Tyr94 side chain.</p>
        <p>(H) A conformational change of the Tyr94 side chain is resolved in the aromatic region of <sup>13</sup>C-HSQC spectra, with HOIP alone (black) and the HOIP OTULIN PIM complex spectrum shown in red. The shifting resonance indicated by an arrow corresponds to the CÎµ of Tyr94. Only the CÎµ region of the aromatic <sup>13</sup>C-HSQC is shown.</p>
        <p>(I) Fluorescent polarization assay of wild-type OTULIN PIM peptide binding to purified HOIP (aa 1â184) PIM pocket mutants. Binding parameters are listed below. Experiments were performed in triplicate, and errors represent SD from the mean.</p>
        <p>(J) Binding of HOIP PUB domain (aa 1â184) to OTULIN peptides (aa 49â67) with the indicated point mutations in the PIM performed as in (I). Binding parameters are listed below.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>FigureÂ 4</label>
      <caption>
        <p>Specificity of the HOIP-OTULIN Interaction</p>
        <p>(A) Close-up view of the HOIP PUB domain (blue) bound to OTULIN PIM (yellow) as in <xref rid="fig3" ref-type="fig">FigureÂ 3</xref>E. Interacting residues are shown in ball-and-stick representation and labeled. Hydrogen bonds are indicated as orange dotted lines.</p>
        <p>(B) Same view as in (A) for the PNGase-p97 complex (PDB ID <ext-link ext-link-type="uri" xlink:href="pdb:2HPL" id="intref0060">2HPL</ext-link>) (<xref rid="bib37" ref-type="bibr">Zhao etÂ al., 2007</xref>). Residues 49â51 that differ structurally from HOIP are colored red.</p>
        <p>(C) PIM peptides from p97 (green) and OTULIN (yellow) can be perfectly superimposed (bottom left) but do not align once PUB domains are superposed because of deeper binding of the OTULIN PIM in the HOIP PIM pocket.</p>
        <p>(D) Fluorescence polarization assays of HOIP N101R/K99R mutants with FITC-Ahx-labeled p97 (797â806) or OTULIN (49â67) PIMs as described in <xref rid="fig2" ref-type="fig">FigureÂ 2</xref>D. Binding parameters are listed below. Experiments were performed in triplicate, and errors represent SD from the mean.</p>
        <p>(E) Superposition on the PIM of PNGase-p97 (orange and green) and HOIP-OTULIN (blue and yellow) shows perfect alignment of the Asn cornerstone residue but also the misalignment of PUB domain core helices, indicating different binding modes.</p>
        <p>(F) Fluorescence polarization assays of PNGase and FITC-Ahx-labeled OTULIN (49â67) with point mutations in the PUB domain and the PIM peptide that promote binding of OTULIN PIM to PNGase. Experiments were performed in triplicate, and errors represent SD from the mean.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>FigureÂ 5</label>
      <caption>
        <p>Verification of HOIP-OTULIN Interactions in Cells</p>
        <p>(A) Experiments performed as in <xref rid="fig1" ref-type="fig">FigureÂ 1</xref>A with HOIP point mutations in the PIM pocket and testing the binding of endogenous OTULIN as detected by an OTULIN antibody.</p>
        <p>(B) HA-tagged OTULIN or OTULIN PIM mutants were expressed in HEK293T cells immunoprecipitated with anti-HA-Agarose resin, and LUBAC components HOIP, HOIL-1, and SHARPIN were detected by western blotting against endogenous components.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="fig6">
      <label>FigureÂ 6</label>
      <caption>
        <p>Functional Consequences of the OTULIN-LUBAC Interaction</p>
        <p>(A) Purification of endogenous Ub conjugates with Met1-specific Ub binding domain (<xref rid="bib16" ref-type="bibr">Keusekotten etÂ al., 2013</xref>) in lysates of HEK293T control and OTULIN-depleted cells transfected with HOIP variants and HOIL-1. Purified material and lysate was examined by immunoblotting. Mutation of the HOIP PIM pocket results in spontaneous accumulation of Met1-linked polyubiquitin on HOIP.</p>
        <p>(B and C) Purification of endogenous Ub conjugates with M1-SUB in U2OS and NOD2 cells transfected with the indicated OTULIN variants and treated with L18-MDP (B) or TNF (C). Purified material was analyzed as in (A). Mutation of the OTULIN PIM impairs stabilization of HOIP ubiquitination by catalytic inactive (C129A) OTULIN under basal conditions and after stimulation.</p>
        <p>(D) NFÎºB reporter activity in lysates of HEK293T cells transfected with HOIL-1, HOIP, or HOIP PIM pocket mutants and with or without the expression of OTULIN. OTULIN abrogated NFÎºB activity induced by wild-type LUBAC but was less effective in inhibiting activity induced by HOIP PIM pocket mutants.</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="fig7">
      <label>FigureÂ 7</label>
      <caption>
        <p>Regulation of OTULIN-LUBAC Complex Formation by Phosphorylation</p>
        <p>(A) Gel filtration analysis of purified bacterial p97 hexamers and full-length OTULIN visualized by Coomassie staining and HEK293ET cell lysates probed with indicated antibodies.</p>
        <p>(B) Schematic of the OTULIN PIM indicating phosphorylation at Tyr56 as identified in 22 independent mass spectrometry experiments in <ext-link ext-link-type="uri" xlink:href="http://phosphosite.org/proteinAction.do?id=2470471" id="intref0065">http://phosphosite.org/proteinAction.do?id=2470471</ext-link>.</p>
        <p>(C) Fluorescence polarization assays of HOIP PUB domains with wild-type and Tyr56-phosphorylated FITC-Ahx-labeled OTULIN (49â67). Experiments were performed in triplicate, and errors represent SD from the mean.</p>
        <p>(D) HEK293ET lysates were prepared in absence of phosphatase inhibitors and probed for the same components as in (A). Only the OTULIN blot is shown.</p>
        <p>(E) Schematic model of the LUBAC-OTULIN complex indicating its regulation by protein phosphorylation.</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
    <table-wrap id="tbl1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Data Collection Statistics</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th/>
            <th>HOIP 1â184</th>
            <th>HOIP 5â180Â + OTULIN 49â67</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td colspan="3">
              <bold>Data Collection</bold>
            </td>
          </tr>
          <tr>
            <td colspan="3">
              <hr/>
            </td>
          </tr>
          <tr>
            <td>Beamline</td>
            <td>Diamond I04</td>
            <td>Diamond I02</td>
          </tr>
          <tr>
            <td>Space group</td>
            <td>C <italic>2</italic></td>
            <td>
              <italic>P 6<sub>1</sub></italic>
            </td>
          </tr>
          <tr>
            <td><italic>a</italic>, <italic>b</italic>, <italic>c</italic> (Ã)</td>
            <td>155.20, 99.57, 173.66</td>
            <td>64.05, 64.05, 172.02</td>
          </tr>
          <tr>
            <td>Î±, Î², Î³ (Â°)</td>
            <td>90.00, 99.88, 90.00</td>
            <td>90.00, 90.00, 120.00</td>
          </tr>
          <tr>
            <td>Wavelength</td>
            <td>0.9794</td>
            <td>0.9795</td>
          </tr>
          <tr>
            <td>Resolution (Ã)</td>
            <td>65.75-3.00 (3.09-3.00)</td>
            <td>55.47-2.00 (2.05-2.00)</td>
          </tr>
          <tr>
            <td>
              <italic>R</italic>
              <sub>merge</sub>
            </td>
            <td>12.6 (45.1)</td>
            <td>12.9 (60.4)</td>
          </tr>
          <tr>
            <td><italic>I</italic> / Ï<italic>I</italic></td>
            <td>6.9 (2.3)</td>
            <td>5.9 (2.0)</td>
          </tr>
          <tr>
            <td>Completeness (%)</td>
            <td>99.6 (99.5)</td>
            <td>99.9 (99.8)</td>
          </tr>
          <tr>
            <td>Redundancy</td>
            <td>2.8 (2.8)</td>
            <td>4.9 (5.2)</td>
          </tr>
          <tr>
            <td colspan="3">
              <hr/>
            </td>
          </tr>
          <tr>
            <td colspan="3">
              <bold>Refinement</bold>
            </td>
          </tr>
          <tr>
            <td colspan="3">
              <hr/>
            </td>
          </tr>
          <tr>
            <td>Resolution (Ã)</td>
            <td>62.61-3.00</td>
            <td>55.47-2.00</td>
          </tr>
          <tr>
            <td>Number of reflections</td>
            <td>52,158</td>
            <td>26,676</td>
          </tr>
          <tr>
            <td><italic>R</italic><sub>work</sub> / <italic>R</italic><sub>free</sub></td>
            <td>21.8 (25.8)</td>
            <td>20.2 (23.5)</td>
          </tr>
          <tr>
            <td>Number of atoms</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td>Protein</td>
            <td>18,228</td>
            <td>3,262</td>
          </tr>
          <tr>
            <td>Ligand/ion</td>
            <td>150</td>
            <td>3</td>
          </tr>
          <tr>
            <td>Water</td>
            <td>16</td>
            <td>281</td>
          </tr>
          <tr>
            <td colspan="3">
              <hr/>
            </td>
          </tr>
          <tr>
            <td colspan="3">
              <bold>B factors</bold>
            </td>
          </tr>
          <tr>
            <td colspan="3">
              <hr/>
            </td>
          </tr>
          <tr>
            <td>Wilson <italic>B</italic></td>
            <td>36.0</td>
            <td>22.4</td>
          </tr>
          <tr>
            <td>Protein</td>
            <td>20.2</td>
            <td>29.8</td>
          </tr>
          <tr>
            <td>Ligand/ion</td>
            <td>43.2</td>
            <td>36.8</td>
          </tr>
          <tr>
            <td>Water</td>
            <td>15.2</td>
            <td>32.8</td>
          </tr>
          <tr>
            <td colspan="3">
              <hr/>
            </td>
          </tr>
          <tr>
            <td colspan="3">
              <bold>rmsd</bold>
            </td>
          </tr>
          <tr>
            <td colspan="3">
              <hr/>
            </td>
          </tr>
          <tr>
            <td>Bond lengths (Ã)</td>
            <td>0.003</td>
            <td>0.002</td>
          </tr>
          <tr>
            <td>Bond angles (Â°)</td>
            <td>0.740</td>
            <td>0.613</td>
          </tr>
          <tr>
            <td>Ramachandran statistics (favored/allowed/outliers)</td>
            <td>97.65/2.26/0.09</td>
            <td>98.38/1.62 /0.0</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Numbers in brackets are for the highest-resolution shell.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>